JOSEPH L. FLEISS, PHD
There is no doubt that significance tests have been abused in epidemiology and in other disciplines: statistically significant associations or differences have, in error, been automatically equated to substantively important ones, and statistically nonsignificant associations or differences have, in error, been automatically equated to ones that are zero. The proper inference from a statistically significant result is that a nonzero association or difference has been established; it is not necessarily strong, sizable or important, just different from zero. Likewise, the proper conclusion from a statistically nonsignificant result is that the data have failed to establish the reality of the effect under investigation. Only if the study had adequate power would the conclusion be valid that no practically important effect exists. Otherwise, the cautious "not proven" is as far as one ought to go.
In part as a reaction to abuses due to misinterpretation, a movement is under way in epidemiology to appropriately cautious fashion, should neither apologize for doing so nor tolerate unreasonable demands to reanalyze their data in a manner contrary to what they believe to be appropriate. The following are a few of the valid applications of tests of significance in epidemiologic research.
Refutation of an Earlier Finding
Suppose that investigator A found a strong association between factors X and Y, but that investigator B believes that the association is fallacious. B is not interested in contemplating the limits of a confidence interval for the measure of association between X and Y, only in establishing that the association is nil. (The association between coffee consumption and cancer of the pancreas is an example.) Sample size formulas and tables2'3 are available to permit B to design a study involving sufficiently many subjects so that a finding of statistical nonsignificance would be accepted as evidence against the reality (or, at least, the practical importance) of the association.
It would be dishonest for B to delete reference to significance tests in the description of the study's methods or in the presentation of its results, whether or not the association he found between X and Y was statistically significant. If the association was statistically nonsignificant, B's point would be made. If it was statistically significant, B would be ethically obliged to say so and, given the context in which the study was conceived, thereby add to the credibility of the association.
Identification of Confounders
There seems to be consensus as to what biological and probability conditions characterize a variable, at least in theory, as a confounder.'5 Whether the biological conditions are satisfied must be assessed by a subject-matter expert, not by a statistician, but the assessment of the probability conditions is a purely statistical problem. As with every important statistical problem, there are several reasonable solutions, not a single right one.
A strategy that my colleagues and I recently felt comfortable applying in a prospective study with many potential confounders was the following. We first identified 22 potential confounders on the basis of the experts' knowledge of the phenomenon being studied and ofthe previous literature. We then identified 15 of them that were associated with exposure at or beyond the 0.01 significance level. Finally, we applied Cox's proportional hazards model6 using the stepdown variable deletion feature of the BMDP2L program7 to identify nine ofthe 15 that were relatively independent one of another and were associated with the outcome variable at or beyond the 0.10 (i.e., V1o) significance level. Only then did we examine the independent effect of the hypothesized risk factor on outcome.
We debated whether the two significance levels should be relaxed or tightened, but we never questioned the appropriateness of relying on tests of significance to identify that subset of the 22 potential confounders that we would control for in our final analysis. Our aim was to make decisionswhich potential confounders would be controlled and which would not-and significance tests provided the explicit and prespecified rules that a reproducible decision-making process required.
Subgroup Analyses and Interactions
Dr. Walker correctly points out that tests for heterogeneity of effect over subgroups (i.e., for interaction) generally have low power. My feeling is that such a state of affairs is appropriate, given that interactions have proven to be notoriously difficult to replicate. One reason is that random misclassification errors in assigning subjects to subgroups may, artifactually, produce an apparent interaction: the appearance of a weak association between exposure and outcome in one subgroup but of a strong association in another. 8 Bringing to bear, as Dr. Walker suggests, "relevant observations external to the study" is not an adequate safeguard against spurious subgroup effects, inasmuch as nearly every conceivable finding can, given sufficient ingenuity, be argued to be biologically plausible.
As a basis for deciding whether to examine associations within subgroups, a formal significance test for interaction provides a measurable degree of protection against pursuing what may be artifactual. I heartily recommend it.
Nonparametric Survival Analysis
It is not true that "(every) important epidemiologic observation (can) be clearly presented in a few tables of raw data with simple summary statistics." Studies in which time to response is the outcome under investigation (time until first occurrence or until recurrence of disease, time until conception, time until death,. etc.) provide an important counterexample. It is the entire estimated survival function, the set of probabilities of remaining disease-free or nonpregnant or alive, that constitutes the not-so-simple summary statistics. If the investigator is willing to make certain assumptions about the mathematical form of the survival function,6'9"10 then an analogue of the relative risk may be defined (the probability that a member of the exposed group who has not yet experienced the outcome during the first T time units of follow-up will experience it during the next short time interval, divided by the corresponding probability for the control group) that is independent of T. The sample relative risk may be tested for significance, but most data analysts would agree that a confidence interval is at least as informative.
Suppose, however, that the investigator is unwilling to make any assumption about the form of the survival function, but nevertheless wishes to determine whether the underlying survival function in the exposed group is the same as that in the control group. The analysis must literally be nonparametric, inasmuch as neither a single parameter nor a finite number of parameters completely describes the differences between the two underlying survival functions. The most popular procedure for testing whether the two sample survival curves differ significantly is known variously as the log-rank test11 and Mantel's adaptation ' 
